Monogenic diabetes
Gene: ZNF808EnsemblGeneIds (GRCh38): ENSG00000198482
EnsemblGeneIds (GRCh37): ENSG00000198482
ZNF808 is in 4 panels
2 reviews
Ida Ertmanska (Genomics England Curator)
PMID: 41500078 Russ-Silsby et al 2026
17 previously unreported individuals with biallelic loss-of-function ZNF808 variants.19 individuals had permanent neonatal diabetes; 12 had other diabetes phenotypes: 5 with infancy-onset diabetes, 4 with transient diabetes and 3 with diabetes diagnosed aged 10, 14 and 23 years.
Variable severity associated with the variants e.g.,:
p.(Thr630Serfs*24) was detected in a homozyogus state in Patient 14 (diabetes diagnosed at 23 yrs), as well as Patient 1 (PNDM diagnosed at 13 weeks), and in patient 11 (transient diabetes diagnosed at 1 day old).
p.(Tyr662*) detected in homozygous state in Patient 15 (diabetes diagnosed at 10yo) and heterozygous, in trans with a deletion, in Patient 13 (diabetes diagnosed at 14 years.Created: 18 Mar 2026, 4:36 p.m. | Last Modified: 18 Mar 2026, 4:36 p.m.
Panel Version: 3.11
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Pancreatic agenesis 3, OMIM:620991; diabetes mellitus, MONDO:0005015
Publications
Kevin Colclough (Royal Devon & Exeter NHS Healthcare Trust)
Biallelic pathogenic protein-truncating/null variants in the ZNF808 gene cause permanent neonatal diabetes (De Franco et al 2023 PMID: 37973953) and the gene is included as a green gene on the R143 neonatal diabetes panel. More recently, the diabetes phenotype has been expanded to include transient neonatal diabetes and monogenic diabetes diagnosed in childhood and early adulthood with a MODY phenotype (Russ-Silsby et al 2026 PMID: 41500078). The paper reports three individuals with biallelic ZNF808 heterozygous loss of function variants diagnosed at ages 10, 14 and 23. All three individuals would meet current eligibility criteria for R141 testing and were in fact patients that previously had negative R141 testing and consented for further testing of ZNF808 on a research basis. Two of these patients were treated with an oral hyperglycaemic agent called a sulphonylurea and responded well to this treatment with good glycaemic control.
Sources: Expert ReviewCreated: 12 Mar 2026, 12:46 p.m.
Mode of inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Phenotypes
Diabetes
Publications
- PMID: 41500078
Variants in this GENE are reported as part of current diagnostic practice
Details
- Mode of Inheritance
- BIALLELIC, autosomal or pseudoautosomal
- Sources
-
- Expert Review Amber
- Phenotypes
-
- Pancreatic agenesis 3, OMIM:620991
- diabetes mellitus, MONDO:0005015
- Clinvar variants
- Variants in ZNF808
- Penetrance
- unknown
- Publications
- Panels with this gene
History Filter Activity
Set Phenotypes
Ida Ertmanska (Genomics England Curator)Phenotypes for gene: ZNF808 were changed from Diabetes to Pancreatic agenesis 3, OMIM:620991; diabetes mellitus, MONDO:0005015
Set publications
Ida Ertmanska (Genomics England Curator)Publications for gene: ZNF808 were set to PMID: 41500078
Entity classified by Genomics England curator
Ida Ertmanska (Genomics England Curator)Gene: znf808 has been classified as Amber List (Moderate Evidence).
Set mode of inheritance
Ida Ertmanska (Genomics England Curator)Mode of inheritance for gene: ZNF808 was changed from MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted to BIALLELIC, autosomal or pseudoautosomal
Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance
Kevin Colclough (Royal Devon & Exeter NHS Healthcare Trust)gene: ZNF808 was added gene: ZNF808 was added to Monogenic diabetes. Sources: Expert Review Mode of inheritance for gene: ZNF808 was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: ZNF808 were set to PMID: 41500078 Phenotypes for gene: ZNF808 were set to Diabetes Penetrance for gene: ZNF808 were set to unknown Review for gene: ZNF808 was set to GREEN gene: ZNF808 was marked as current diagnostic